Remerica Inc – Trademark Portfolio

Entity Type: 03

Remerica Inc holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include REMERICA. The owner is based in Plymouth, MI.

41017 Ann Arbor Road

Plymouth, MI 48170

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Remerica Inc's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (4 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Remerica Inc have?

Remerica Inc has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.

What trademark classes does Remerica Inc file in?

Remerica Inc files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 16 (Paper Goods). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Remerica Inc's most well-known trademarks?

Remerica Inc's registered trademark portfolio includes well-known marks such as REMERICA. These are among 1 currently registered trademark in the portfolio.

What is Remerica Inc's trademark registration success rate?

Remerica Inc has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.